In addition, while this study primarily focuses on the role of the USP4/PPARα signaling pathway in Lgr6‐mediated regulation of pathological cardiac hypertrophy, we acknowledge that other potential mechanisms may exist and warrant further investigation in the future. The gene discussed is LGR6; the disease is cardiac hypertrophy.